Abvc Biopharma Inc Expected To Post A Loss Of 15 Cents A Share: Earnings Preview

ABVC Biopharma

31/03/2023 21:09

* ABVC Biopharma Inc  ABVC.OQ   ABVC.O  is expected to show
a rise
in quarterly revenue when it reports  results on April 3
(estimated). 
    * The Fremont California-based  company is expected to
report  a
134.2% decrease in revenue to $13 thousand from $-38 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ABVC Biopharma Inc
is for
a loss of 15 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $2.02​, above​ its last closing price of $0.62. ​​​

This summary was machine generated March 31 at 20:09 GMT.  All
figures in US dollars  unless otherwise stated